Vimarsana
Biggest News Aggregation in the World

Page 4 - Clinical Program Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Program Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Program Updates Today - Breaking & Trending Today

CORRECTION -- Gritstone Reports First Quarter 2022 - Vimarsana News

CORRECTION -- Gritstone Reports First Quarter 2022

-- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data...

CORRECTION -- Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

CORRECTION -- Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
2022-05-05 | NDAQ:GRTS | Press Release | Gritstone bio Inc. - Vimarsana News

2022-05-05 | NDAQ:GRTS | Press Release | Gritstone bio Inc.

(2022-05-05 | NDAQ:GRTS) Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update

FUSN PHAR : Fusion Pharmaceuticals Announces Fourth Quarter 2021 Financial Results and Clinical Program Updates - Form 8-K - Vimarsana News

FUSN PHAR : Fusion Pharmaceuticals Announces Fourth Quarter 2021 Financial Results and Clinical Program Updates - Form 8-K

Fusion Pharmaceuticals Announces Fourth Quarter 2021 Financial Results and Clinical Program Updates - Company is advancing first targeted... | March 17, 2022

IMV Inc. Announces Fourth Quarter and Full Year 2020 Financial and Operational Results - Vimarsana News

IMV Inc. Announces Fourth Quarter and Full Year 2020 Financial and Operational Results

Press release content from Business Wire. The AP news staff was not involved in its creation. IMV Inc. Announces Fourth Quarter and Full Year 2020 Financial and Operational Results March 17, 2021 GMT DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--Mar 17, 2021-- IMV Inc. (the “Company” or “IMV”) (TSX: IMV; NASDAQ: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced its financial and operational results for the fourth quarter and year ended December 31, 2020. “Notwithstanding the challenges everyone faced in 2020, IMV’s commitment ...

Source: apnews.com